Trials / Completed
CompletedNCT04384991
HU007 Eye Drops in Patients With Dry Eye Syndrome
A Multicenter, Randomized, Double Blind, Restasis-controlled Non-inferiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 216 (actual)
- Sponsor
- Huons Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, randomized, double blind, Restasis-controlled non-inferiority, Phase III Study to evaluate the efficacy and safety of HU007 eye drops in patients With dry eye syndrome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HU007 | Cyclosporine 0.02% with Trehalose 3% |
| DRUG | Restasis eye drop | Cyclosporine 0.05% |
Timeline
- Start date
- 2019-05-03
- Primary completion
- 2019-12-05
- Completion
- 2019-12-05
- First posted
- 2020-05-12
- Last updated
- 2020-05-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04384991. Inclusion in this directory is not an endorsement.